Merck may have to wait until 2013 before the FDA reconsiders approval of its cholesterol drug known as Cordaptive (MK-0524A).

Contract sales firm PDI has announced the retirement of its CEO Michael Marquard.

WebMD is bringing in less ad money and facing increased competition from smaller, similar websites, Wall Street analysts said this week.

Pfizer bought some extra time for its blockbuster cholesterol drug Lipitor (atorvastatin) by reaching a settlement with Ranbaxy Laboratories delaying the US launch of a generic version of the world's top selling pharmaceutical brand.

Although four million people have tried GlaxoSmithKline's OTC weight loss drug Alli during its first year on the market, preliminary sales figures are "pretty underwhelming," one analyst tells the Associated Press.

Revolution Health Group has reduced its staff by 50 employees as the online consumer health company reshuffles for the second time in eight months.

Nonprofit health maintenance organization (HMO) Kaiser Permanente has partnered with Microsoft in its push for electronic consumer-controlled health records.

Pfizer's smoking cessation treatment Chantix was the top-searched prescription brand online in February, generating more than 500,000 search queries, according to internet measurement firm comScor

WebMD parent company WebMD Health Corp has revised its outlook due to a lack of healthcare advertisers spending money with the firm.

Will the Institute of Medicine's investigation into med ed conflicts of interest change the face of an industry?